DEA Evaluates Scottsdale Research Institute Application to Bulk Manufacture Marihuana
February 13, 2026
February 13, 2026
WASHINGTON, Feb. 13 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration announced that Scottsdale Research Institute, Phoenix, Arizona, has applied to be registered as a bulk manufacturer of several Schedule I controlled substances.
The request involves the following substances:
* Marihuana
* Marihuana Extract
* Tetrahydrocannabinols
The institute intends to manufacture these substances to support clinical tri . . .
The request involves the following substances:
* Marihuana
* Marihuana Extract
* Tetrahydrocannabinols
The institute intends to manufacture these substances to support clinical tri . . .
